{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:04:06Z","timestamp":1747159446332,"version":"3.40.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Egyptian Heart Journal"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ehj.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T05:54:36Z","timestamp":1519970076000},"page":"135-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and predictors of bleeding among Egyptian patients presenting with acute coronary syndrome: Using CRUSADE risk score"],"prefix":"10.1186","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-1097","authenticated-orcid":false,"given":"Ayman","family":"Morttada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.ehj.2018.01.004_b0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/heartjnl-2011-300129","article-title":"Francisco: use of risk scores in acute coronary syndrome","volume":"98","author":"Bueno","year":"2012","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ehj.2018.01.004_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.recesp.2011.08.005","article-title":"Assessing bleeding risk in acute coronary syndromes","volume":"65","author":"Erdem","year":"2012","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.ehj.2018.01.004_b0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11886-010-0119-4","article-title":"What goes into a major acute coronary syndrome trial and what will future trials look like?","volume":"12","author":"Guliz","year":"2010","journal-title":"Curr Cardiol Rep"},{"issue":"38","key":"10.1016\/j.ehj.2018.01.004_b0020","first-page":"3209","article-title":"Bleeding complication after treatment with clopidogrel and acetylsalicylic acid after acute coronary syndrome","volume":"168","author":"Kjaer","year":"2006","journal-title":"Ugeskr Laeger"},{"issue":"4","key":"10.1016\/j.ehj.2018.01.004_b0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/HCO.0b013e3283021c5b","article-title":"The risk of iatrogenic bleeding in acute coronary syndrome and long-term mortality","volume":"23","author":"Sobieraj-Teague","year":"2008","journal-title":"Curr Opin Cardiol"},{"issue":"9","key":"10.1016\/j.ehj.2018.01.004_b0030","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2459\/JCM.0b013e3283299808","article-title":"Clinical implications and management of bleeding events in patients with acute coronary syndromes","volume":"10","author":"De Luca","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"23","key":"10.1016\/j.ehj.2018.01.004_b0035","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A risk score to predict bleeding in patients with acute coronary syndromes","volume":"55","author":"Mehran","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ehj.2018.01.004_b0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3949\/ccjm.77a.09142","article-title":"Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes","volume":"77","author":"Gutierrez","year":"2010","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ehj.2018.01.004_b0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2147\/VHRM.S23862","article-title":"Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention","volume":"7","author":"Pham","year":"2011","journal-title":"Vasc Health Risk Manage"},{"key":"10.1016\/j.ehj.2018.01.004_b0050","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in Non ST Segment: the CRUSADE bleeding score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ehj.2018.01.004_b0060","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1053\/euhj.2000.2474","article-title":"The clopidogrel in UA to prevent recurrent events (CURE) trial programm; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease","volume":"21","author":"CURE Study Investigators","year":"2000","journal-title":"Eur Heart J"},{"issue":"9281","key":"10.1016\/j.ehj.2018.01.004_b0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing PCI: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ehj.2018.01.004_b0070","first-page":"378","article-title":"Assessment and management of ACS: a Canadian perspective on current guidelines recommendations treatment in NSTEMI","volume":"27","author":"David","year":"2011","journal-title":"Canadian J Cardiol"},{"key":"10.1016\/j.ehj.2018.01.004_b0075","doi-asserted-by":"crossref","unstructured":"Pham Phuong-Anh, Pham Phuong-Thu, et al. Implications of bleeding in ACS and percutaneous coronary intervention. Dove Press J. 2011:7:551\u2013567.","DOI":"10.2147\/VHRM.S23862"},{"key":"10.1016\/j.ehj.2018.01.004_b0080","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/eurheartj\/ehn008","article-title":"Impact of anticoagulation levels on outcomes in patients undergoing elective PCI: insights from the STEEPLE trial. Bleeding complications with platelet glycoprotein IIb\/IIIa receptor antagonists","volume":"29","author":"Montalescot","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ehj.2018.01.004_b0085","doi-asserted-by":"crossref","unstructured":"Lopes RD, Alexander KP, et al. Outcomes in elderly patients with ACS randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial. Eur Heart J. 2008;29(15):1827\u20131833.","DOI":"10.1093\/eurheartj\/ehn236"},{"key":"10.1016\/j.ehj.2018.01.004_b0090","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Mosucci","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ehj.2018.01.004_b0095","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0002-9149(03)00972-X","article-title":"Incidence, predictors, and prognostic implications of bleeding and blood transfusion following PCI","volume":"92","author":"Kinnaird","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ehj.2018.01.004_b0105","unstructured":"Kjaer J., Larsen CH, et al. Bleeding complications after treatment with clopidogrel and acetyl salicylic acid after acute coronary syndrome. Ugesk Laeger. 2006;168(38): 3209\u20133216."},{"key":"10.1016\/j.ehj.2018.01.004_b0110","first-page":"190","article-title":"Rationale and design of the GRACE (Global Registry of Acute Coronary Events","volume":"141","author":"Global registry of acute coronary events project","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ehj.2018.01.004_b0115","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/CIRCULATIONAHA.107.694273","article-title":"Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?","volume":"116","author":"Spencer","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ehj.2018.01.004_b0120","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.amjcard.2007.06.026","article-title":"Predictors and impact of major hemorrhage on mortality from the REPLACE-2 trial","volume":"100","author":"Feit","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ehj.2018.01.004_b0125","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2004.03.080","article-title":"Impact of anemia in patients with AMI undergoing primary PCI: (CADILLAC) Trial","volume":"44","author":"Nikolsky","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ehj.2018.01.004_b0130","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes from the ACUITY trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ehj.2018.01.004_b0135","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2008.12.021","article-title":"Advanced age, antithrombotic strategy, and bleeding in NSTEMI: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial","volume":"53","author":"Lopes","year":"2009","journal-title":"JACC"},{"key":"10.1016\/j.ehj.2018.01.004_b0140","first-page":"115","article-title":"Choice of arterial access site and outcomes in patients ACS managed with an early invasive strategy: the ACUITY trial","volume":"5","author":"Hamon","year":"2009","journal-title":"Euro Interv"},{"key":"10.1016\/j.ehj.2018.01.004_b0145","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3346\/jkms.2013.28.9.1307","article-title":"The impact of vascular access for in-hospital major bleeding in patients with ACS at moderate to very-high bleeding risk","volume":"28","author":"Park","year":"2013","journal-title":"J Korean Med Sci"},{"issue":"1","key":"10.1016\/j.ehj.2018.01.004_b0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2008.02.008","article-title":"The harmonizing outcomes with revascularization and stents in AMI (HORRIZONS AMI): study design and rationale","volume":"156","author":"Mehran","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ehj.2018.01.004_b0155","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jacc.2007.11.081","article-title":"Safety and efficacy of bivalirudin monotherapy in patients with DM and ACS: a report from the ACUITY trial","volume":"51","author":"Feit","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ehj.2018.01.004_b9000","unstructured":"The Fifth Organization to Assess Strategies in Acute Ischemic yndromes (OASIS-5) investigators and committees. N Engl J Med 2006;354:1464\u201376."}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110260817301850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110260817301850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T00:33:34Z","timestamp":1570840414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1110260817301850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1110260817301850"],"URL":"https:\/\/doi.org\/10.1016\/j.ehj.2018.01.004","relation":{},"ISSN":["1110-2608"],"issn-type":[{"type":"print","value":"1110-2608"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and predictors of bleeding among Egyptian patients presenting with acute coronary syndrome: Using CRUSADE risk score","name":"articletitle","label":"Article Title"},{"value":"The Egyptian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ehj.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}